Biom’up Finalizes U.S. Commercial Organization to Support U.S. Launch of HEMOBLAST™ Bellows U.S. team of more than 100 specialist sales representatives & seasoned management in place  On track with clinical, regulatory, financial, and commercial milestones SAINT-PRIEST, France, May ...

Biom’up Has Trained 200 Surgeons in its International KOL-Led Program Ahead of HEMOBLAST Bellows™ Launch 200 KOLs and surgeons trained across the U.S. and Europe to date Objective is to continue training a maximum of surgeons before the official launch of HEMOBLAST Bellows in mid-2018 NEW YORK and...

Biom'up reports 2017 full-year results and provides corporate update 2017 results underscore focus on establishing a strong financial foundation as basis for commercial strategy going forward A total of €100 million raised through 2017 to date Marketing approval lead...

Biom’up Appoints Thierry Darnis as Global Vice President, Manufacturing & Engineering SAINT-PRIEST, France, March 26, 2018 (GLOBE NEWSWIRE) -- Biom’up, specialist of surgical hemostasis, today announced the appointment, effective May 2, 2018, of Thierry Darnis as Global Vice...